Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers Pioneer Treatment for Viral Infection Common in Children

Published: Thursday, June 13, 2013
Last Updated: Thursday, June 13, 2013
Bookmark and Share
Professor Peter Openshaw and team develops a new technique used in tackling a wide range of other diseases.

Researchers at Imperial College London have discovered a new way in which a very common childhood disease could be treated.

In the first year of life, 65 per cent of babies get infected by Respiratory Syncytial Virus (RSV). This causes bronchiolitis, and is thought to kill nearly 200,000 children every year worldwide.

In 1966 and 1967, vaccines were tested for RSV. These had disastrous effects on the immune response, leading to a worsening of the disease and, in many cases, death. Scientists have so far not been able to fully explain this effect, which continues to hold back vaccine development.

Studying this effect in mice, Imperial’s Professor Peter Openshaw and his team developed a new technique which they hope might be used in tackling a wide range of other diseases including viral bronchiolitis.

In a paper published in the Proceedings of the National Academy of Sciences, the researchers examined how the RSV vaccine boosts white blood cells that respond to infection, making them flock to the lungs and blocking the tubes that supply oxygen.

They found that the vaccine boosted the accumulation of these T cells, but also virtually eliminated the regulatory immune response in the lungs caused cells known as Tregs.

Professor Openshaw said: “The reason for the vaccine’s failure has been a puzzle for over 40 years. To solve it, we tested out new ideas about how the immune system slows down inflammation. If it doesn’t regulate itself properly, inflammation can run out of control. This vaccine seems to have locked the accelerator in the on position and to have disabled the brakes.

Next, the team tested the effects of chemokines, proteins which cause nearby cells to move from place to place in the body. They found that when vaccinated mice inhaled the chemokines, Tregs were attracted back into the lungs where they reduced inflammation and helped to fight infection.

Professor Openshaw added “This is a very important discovery - it represents an entirely new way to treat these inflammatory diseases.”

If this approach were to work in patients, it could be used in a wide range of conditions in which there is excessive inflammation such as arthritis or psoriasis as well as bronchiolitis.

Openshaw’s group hope that by gaining a better understanding of RSV disease they may at last be able to understand why some babies get so seriously ill, whereas others make a quick recovery.

This knowledge could lead progress in reducing RSV’s global impact and in the development of safe, and effective, vaccines.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Protein That Boosts Immunity to Viruses and Cancer Discovered
Researchers now developing a gene therapy designed to boost the infection-fighting cells.
Saturday, April 18, 2015
Protein That Boosts Immunity To Viruses And Cancer Discovered
Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies.
Friday, April 17, 2015
Adults Only Really Catch Flu About Twice a Decade, Suggests Study
Researchers developed a mathematical model of how our immunity to flu changes over a lifetime as we encounter different strains of the virus.
Thursday, March 05, 2015
Scientists Uncover New Role for Neurotransmitter that Helps Fight Infection
Scientists have shed new light on the complexities of the immune system that could help develop vaccines to boost natural defences against disease.
Wednesday, February 25, 2015
Epigenetic Study Highlights Drug Targets for Allergies and Asthma
Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.
Saturday, February 21, 2015
New Class of Antibodies Raises Hope of Dengue Fever Vaccine
Scientists have discovered a new class of human antibodies against the dengue fever virus, which could be exploited to develop a vaccine.
Tuesday, February 03, 2015
Monitoring Effectiveness Of Hay Fever Immunotherapy
A new test for measuring histamine release from certain white blood cells could help doctors monitor the effectiveness of immunotherapy for hay fever.
Monday, November 24, 2014
Study Finds Potential New Target to Treat Asthma Attacks Brought on by Colds
Results suggest that IL-25 could be a target for possible treatments to prevent asthma attacks.
Tuesday, October 07, 2014
Injected Vaccine Could Help Eradicate Polio
Re-introducing a type of polio vaccine that fell out of favour in the 1960s could hasten eradication of the disease.
Friday, July 11, 2014
New Clues to How Bacteria Evade Antibiotics
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics.
Friday, January 10, 2014
Scientists Closer to Universal Flu Vaccine After Pandemic “Natural Experiment”
The findings are published in Nature Medicine.
Friday, October 04, 2013
Flu is Transmitted Before Symptoms Appear, Study Suggests
ICL researchers examine influenza transmission in ferrets.
Wednesday, September 05, 2012
New Dean Appointed to Joint Medical School of Imperial College London and NTU
Immunology and infectious diseases pioneer, Professor Dermot Kelleher, to lead Lee Kong Chian School of Medicine.
Monday, August 06, 2012
Old Antibiotic could be a New Weapon to Fight TB
A cheap and safe antibiotic that is widely available in the developing world might have a new use as a TB treatment, according to new research.
Friday, February 17, 2012
Professor Dermot Kelleher Named as Principal of the Faculty of Medicine at ICL
Professor Kelleher is one of Ireland's foremost medical leaders and a pioneer in the field of immune response and infectious disease.
Monday, January 16, 2012
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!